Sijing Cheng

26 Yuancun Erheng Road
Guangzhou, 510655, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Lactate-associated transcriptomic alterations and malignant phenotypes in colorectal cancer.

Lactate-associated transcriptomic alterations and malignant phenotypes in colorectal cancer.

Journal: Discover oncology

Published: November 25, 2025

Magnetic Resonance Imaging Features as Predictors of Response and Prognosis Following Neoadjuvant Therapy in Rectal Cancer: A Retrospective Cohort Study.

Magnetic Resonance Imaging Features as Predictors of Response and Prognosis Following Neoadjuvant Therapy in Rectal Cancer: A Retrospective Cohort Study.

Journal: Clinical Medicine Insights. Oncology

Published: November 17, 2025

KRAS amplification in colorectal cancer: correlations with clinicopathological features and prognosis in patients and prediction of response to targeted therapy.

KRAS amplification in colorectal cancer: correlations with clinicopathological features and prognosis in patients and prediction of response to targeted therapy.

Journal: Journal of translational medicine

Published: March 19, 2025

Bazedoxifene attenuates dextran sodium sulfate-induced colitis in mice through gut microbiota modulation and inhibition of STAT3 and NF-κB pathways.

Bazedoxifene attenuates dextran sodium sulfate-induced colitis in mice through gut microbiota modulation and inhibition of STAT3 and NF-κB pathways.

Journal: European journal of pharmacology

Published: January 03, 2024

Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death.

Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death.

Journal: Nature communications

Published: April 18, 2023

Mutant KRAS Drives Immune Evasion by Sensitizing Cytotoxic T-Cells to Activation-Induced Cell Death in Colorectal Cancer.

Mutant KRAS Drives Immune Evasion by Sensitizing Cytotoxic T-Cells to Activation-Induced Cell Death in Colorectal Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 29, 2022

Correlation between altered gut microbiota and elevated inflammation markers in patients with Crohn's disease.

Correlation between altered gut microbiota and elevated inflammation markers in patients with Crohn's disease.

Journal: Frontiers in immunology

Published: May 18, 2022

The Proinflammatory Role of Guanylate-Binding Protein 5 in Inflammatory Bowel Diseases.

The Proinflammatory Role of Guanylate-Binding Protein 5 in Inflammatory Bowel Diseases.

Journal: Frontiers in microbiology

Published: April 23, 2022

IBD Subtype-Regulators IFNG and GBP5 Identified by Causal Inference Drive More Intense Innate Immunity and Inflammatory Responses in CD Than Those in UC.

IBD Subtype-Regulators IFNG and GBP5 Identified by Causal Inference Drive More Intense Innate Immunity and Inflammatory Responses in CD Than Those in UC.

Journal: Frontiers in pharmacology

Published: February 04, 2022

Altered gut microbiome in FUT2 loss-of-function mutants in support of personalized medicine for inflammatory bowel diseases.

Altered gut microbiome in FUT2 loss-of-function mutants in support of personalized medicine for inflammatory bowel diseases.

Journal: Journal of genetics and genomics = Yi chuan xue bao

Published: July 18, 2021

Gastrointestinal sequelae 90 days after discharge for COVID-19.

Gastrointestinal sequelae 90 days after discharge for COVID-19.

Journal: The lancet. Gastroenterology & hepatology

Published: February 15, 2021

Adverse Outcomes Associated With Corticosteroid Use in Critical COVID-19: A Retrospective Multicenter Cohort Study.

Adverse Outcomes Associated With Corticosteroid Use in Critical COVID-19: A Retrospective Multicenter Cohort Study.

Journal: Frontiers in medicine

Published: September 09, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026